Site of Health  Ministry
Site of Brazilian Government

National System of Sanitary Surveillance
Generic Drugs
Medicine Bioavailability Bioequivalence Centers
Travelers Information
Severe Acute Respiratory Syndrome

Legislation

Resolution - RDC nš 67, 14 July 2000
(DO dated 07/17/00)

As the Chairman-Chairman of the Brazilian Sanitary Surveillance Agency, ANVISA, in the use of the attributions vested in it, in compliance with article 13, item IV, of the Regulation of this Agency, approved by Decree n. 3.029, dated April 16, 1999, combined with article 7 of Law nº 6.360 dated 23 September 1976, article 4 paragraph 1, item I of Decree nº 3.029 dated 16 April 1999, article 7 item XV of Law nº 9.782 dated 26 January 1999 and article 8, caput, and its sole paragraph, of Decree nº 79.094 dated 05 January 1977.

WHEREAS the reports of the General Management of the Technical Advisory Commission on Medication – CONATEM, and WHEREAS the urgency of the subject, I, ad referendum, adopt the following Resolution of the Collegiate Directorate and determine its publication:

Art. 1 To suspend as of this date, as a measure of sanitary interest, the fabrication, distribution, trade/sale and dispensation of products that contain the substance TERFENADINE and its salts in their formula, be it in isolation or in association to other substances.

Art. 2 To grant a period of 90 (ninety) days for companies that have a license of the products containing the substance TERFENADINE to withdraw their products from the national territory. Sole Paragraph. Failure to comply with the provisions contained in this resolution shall subject the offenders to the penalties provided for in Law nº 6.437, dated 20 August 1977.

Art. 3 This Resolution of the Collegiate Directorate shall enter into force on the date of its publication.

Gonzalo Vecina Neto

 
 
Copyright 2003 - Anvisa
Ombusdman Advisory Council